Aldeyra Therapeutics Financials - Benzinga

Aldeyra Therapeutics Inc

ALDXNASDAQ

Trade with Public

Trade with Public

$1.48

-0.005-0.34%

At close: Aug 31, 5:00 PM EST

$1.56

0.085.41%

After Hours: 5:48 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Aldeyra Therapeutics Financials

Aldeyra Therapeutics (ALDX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Crude Oil Dips 7%; ISM Services PMI Falls In March

Avi Kapoor

Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

Avi Kapoor

Crude Oil Moves Lower; Consolidated Communications Shares Jump

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&P 500 also rose, gaining, 1.11% to 4,375.72.

Lisa Levin

Nasdaq Gains 1%; Charles Schwab Earnings Top Views

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P 500 also rose, gaining, 1.03% to 4,372.52.

Lisa Levin

Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also rose, gaining, 0.60% to 4,353.60.

Lisa Levin

Recap: Aldeyra Therapeutics Q1 Earnings

Benzinga Insights